Wilson Sonsini is proud to be a part of ACI's Inaugural Life Sciences AI Summit. The legal, regulatory, and compliance event for safe and responsible innovation in the biopharma and medical device/diagnostic industries.

On February 22nd at 3:45 pm Wilson Sonsini partner Eva F. Yin will be co-presenting, AI in Action: Enhancing Clinical Decision-Making with AI, with Michelle Francis, Senior Corporate Counsel, Microsoft Health & Life Sciences, at Microsoft. The discussion with cover:

• Exploring how AI assists healthcare providers in making informed treatment decisions
• Addressing FDA’s oversight of clinical decision support software and its implications for patient care
• Evaluating the post-market surveillance and modifications of AI-powered clinical decision support (CDS) tools
• Controlling disease diagnosis and medical imaging
• Harnessing Ai in enhancing the accuracy, speed, and consistency of medical imaging interpretation
• Defining the challenges and opportunities of implementing AI in radiology and pathology
• Discussing the transformative impact of AI on precision medicine and targeted treatments
• Balancing data privacy concerns with the need for comprehensive datasets to train and refine these types of AI models